What to Expect at a Hair Restoration Consultation

A hair restoration consultation is the structured clinical evaluation that determines whether a patient is a surgical or medical candidate, which procedures are appropriate, and what realistic outcomes can be anticipated. The process typically unfolds across distinct phases — history-taking, scalp examination, classification scoring, and treatment planning — each governed by clinical protocols and, depending on the setting, applicable federal and state regulatory frameworks. Understanding the structure of this appointment helps patients arrive prepared and evaluate provider recommendations with greater accuracy.

Definition and Scope

A hair restoration consultation is a formal medical encounter, not a sales meeting. The American Board of Hair Restoration Surgery (ABHRS), one of the primary certifying bodies for this specialty, distinguishes between evaluative consultations performed by a qualified physician and informational sessions conducted by patient coordinators or non-physician staff. The distinction matters because the diagnostic components — scalp biopsy referral, laboratory workup orders, and prescription medication planning — require physician licensure under state medical practice acts.

The scope of the consultation spans surgical and non-surgical pathways. Surgical options include Follicular Unit Extraction (FUE), Follicular Unit Transplantation (FUT), and robotic hair transplant systems. Non-surgical pathways reviewed at consultation include Platelet-Rich Plasma therapy, low-level laser therapy, scalp micropigmentation, and pharmaceutical interventions. The regulatory context for hair restoration shapes which devices and drugs can be discussed in a clinical recommendation context — for example, only FDA-cleared or FDA-approved devices and drugs may be prescribed or recommended as treatments within the United States.

For a broader orientation to evaluation and candidacy resources, the Hair Restoration Authority index organizes the full reference structure used throughout this site.

How It Works

A standard consultation follows a sequential clinical framework. The numbered phases below reflect the structure described in guidelines published by the International Society of Hair Restoration Surgery (ISHRS), the largest professional organization in this field with membership across more than 70 countries.

Medical and family history intake — The clinician documents personal and family history of hair loss, current medications, prior procedures, and any systemic conditions (thyroid disorders, autoimmune disease, nutritional deficiencies) that may confound diagnosis or contraindicate surgery.
Scalp and hair density examination — A trichoscopic or dermoscopic examination assesses follicle miniaturization patterns, scalp skin condition, and donor zone density. Donor density is typically quantified in follicular units per square centimeter; a density below approximately 40 follicular units per cm² may limit surgical options.
Classification and staging — Male pattern hair loss is staged using the Norwood Scale (a 7-stage system). Female pattern loss is staged using the Ludwig Scale (a 3-stage system). These classifications directly inform graft estimates and procedural sequencing.
Donor zone assessment — The safe donor area — the occipital and parietal scalp zones with DHT-resistant follicles — is mapped. Total harvestable grafts are estimated based on density measurements, laxity, and surface area.
Treatment planning and alternatives review — The physician presents a ranked set of options with associated graft counts, session estimates, and expected timelines to visible growth (typically 9–14 months for transplanted hair to fully mature).
Laboratory or ancillary testing orders — Where etiology is unclear, blood panels (ferritin, TSH, complete blood count, hormonal panels) or biopsy referrals are issued. Scalp biopsy interpretation under a dermatopathologist is the diagnostic standard for conditions such as scarring alopecia and alopecia areata.

Photographic documentation is standard practice. The ISHRS Clinical Guidelines recommend standardized photography under consistent lighting conditions to permit objective pre- and post-procedure comparison.

Common Scenarios

Androgenetic alopecia in male patients — The most common presentation. A Norwood III–V patient with adequate donor density is typically evaluated as a surgical candidate. The consultation will estimate total lifetime graft demand against available donor supply, since androgenetic alopecia is progressive. Concurrent pharmaceutical management with FDA-approved finasteride or over-the-counter minoxidil is frequently discussed as adjunct therapy to slow further loss.

Female pattern hair loss — Female patients present with diffuse thinning rather than the defined recession patterns seen in males. The hair restoration for women evaluation pathway differs substantially: donor zone instability is more common, making many women poor surgical candidates. Medical management, PRP, and LLLT are frequently prioritized at consultation.

Post-chemotherapy or trauma-related hair loss — Patients presenting after chemotherapy or burn injury require timing assessment before surgical planning. Hair restoration after chemotherapy generally requires a confirmed regrowth plateau, typically 12–18 months post-treatment, before transplant candidacy can be evaluated. Burn and trauma scar cases require assessment of recipient site vascularity, which determines graft survival probability.

Ethnic and hair-type variation — Curl pattern, follicle angle, and shaft diameter vary significantly across patient populations and affect extraction technique selection. Hair restoration considerations by hair type are addressed during the donor and recipient site assessments.

Decision Boundaries

The consultation produces one of 4 defined outcomes:

Surgical candidacy confirmed — Adequate donor density, stable recipient zones, realistic expectations, and absence of medical contraindications.
Medical management only — Insufficient donor supply, active disease process, or staging too early for surgical intervention.
Deferred pending workup — Diagnosis unclear; laboratory results, biopsy, or specialist consultation required before a recommendation can be made.
Not a candidate — Diffuse unpatterned alopecia, advanced scarring alopecia affecting donor zones, or systemic conditions precluding elective surgery.

The boundary between surgical and non-surgical candidacy is examined in detail at Am I a Candidate for a Hair Transplant?. Patients should also review questions to ask a hair restoration doctor and verify board certifications for hair restoration surgeons before committing to a treatment plan.

Clinics operating within accredited surgical facilities are subject to oversight by bodies such as the Accreditation Association for Ambulatory Health Care (AAAHC) or The Joint Commission, depending on facility type. State medical boards regulate physician conduct at the consultation level. Advertising claims made during consultations are subject to Federal Trade Commission (FTC) guidelines on testimonials and endorsements.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)